AREG and colorectal carcinoma: These findings provide a deeper understanding of drug resistance development in CRC under obese conditions and offer new insights into the correlation between an abnormal increase in AREG levels and the development of 5-FU resistance in CRC cells, which should be considered in future clinical applications.